Head-To-Head Study Of Treatments For Chemotherapy-Related Anemia Published In The Oncologist

... A study published in the September 2005 issue of The Oncologist demonstrated that PROCRIT® (Epoetin alfa) increased hemoglobin - or red blood cell - levels more than Aranesp® (darbepoetin alfa) in patients with cancer and anemia caused by chemotherapy. In fact, within four weeks of initiating therapy, 47 percent of patients treated with PROCRIT® achieved the primary endpoint of the study, an increase in hemoglobin of one gram or more per deciliter of blood (g/dL), compared to 33 percent of patients who were treated with Aranesp®... click link for more info. ...